LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Catalent Inc

Search

Catalent Inc

Closed

Sector Healthcare

58.55 0.26

Overview

Share price change

24h

Current

Min

57.97

Max

58.68

Key metrics
By Trading Economics
Income	105M -101M
Sales	96M 1.1B
P/E Sector Avg	28.82 79.786
EPS	0.21
Profit margin	-9.018
EBITDA	83M 105M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+8.43 upside

Dividends
By Dow Jones
Next Earnings	27 Aug 2024

Market Stats
By TradingEconomics
Market Cap	347M 10B
Previous open	58.29
Previous close	58.55

News Sentiment

By Acuity

50%

50%

123 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

58.07 / N/A Support & Resistance

Catalent Inc Chart

Related News

3 May 2024, 13:51 UTC

Acquisitions, Mergers, Takeovers

FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal

5 Feb 2024, 14:50 UTC

Acquisitions, Mergers, Takeovers

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 4th Update

5 Feb 2024, 13:11 UTC

Acquisitions, Mergers, Takeovers

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 3rd Update

5 Feb 2024, 12:09 UTC

Acquisitions, Mergers, Takeovers

Novo Holdings to Buy Catalent in $16.5 Billion Deal -- 2nd Update

5 Feb 2024, 11:38 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk Buys Manufacturing Sites as Part of Novo Holdings' Acquisition of Catalent

5 Feb 2024, 11:31 UTC

Acquisitions, Mergers, Takeovers

Novo Holdings Buying Catalent in $16.5 Billion Deal -- Update

5 Feb 2024, 11:23 UTC

Acquisitions, Mergers, Takeovers

Novo Holdings Buying Catalent in $16.5 Billion Deal

23 Mar 2024, 13:00 UTC

Top News

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

5 Feb 2024, 18:04 UTC

Acquisitions, Mergers, Takeovers

Wegovy Maker to Boost Production Capacity With Multibillion-Dollar Deal -- WSJ

5 Feb 2024, 17:27 UTC

Earnings

Acquisitions, Mergers, Takeovers

Novo Nordisk Makes the Latest Big Pharma Deal. Why More Are Coming. -- Barrons.com

5 Feb 2024, 15:36 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk To Up Production Capacity As Parent Buys Catalent -- IBD

5 Feb 2024, 11:38 UTC

Acquisitions, Mergers, Takeovers

Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk -- Barrons.com

5 Feb 2024, 11:15 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk's Controlling Shareholder To Buy Catalent For $16.5 Billion -- MarketWatch

5 Feb 2024, 11:08 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk: Manufacturing Sites Are in Italy, Belgium and US

5 Feb 2024, 11:08 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk Buys Sites From Novo Holdings as Part of Novo Holdings' Deal to Buy Catalent

5 Feb 2024, 11:06 UTC

Acquisitions, Mergers, Takeovers

Novo Nordisk Agrees to Buy Three Manufacturing Sites For Upfront Payment of $11 Bln

5 Feb 2024, 11:03 UTC

Acquisitions, Mergers, Takeovers

Catalent: Merger Is Expected to Close Towards the End of Calendar Yr 2024 >CTLT

5 Feb 2024, 11:02 UTC

Acquisitions, Mergers, Takeovers

Catalent: Of Co's More Than 50 Global Sites, Novo Holdings Intends to Sell Three Catalent Fill-Finish Sites and Related Assets Acquired in Merger to Novo Nordisk >CTLT

Peer Comparison

Price change

Catalent Inc Forecast

Price Target

By TipRanks

8.43% upside

12 Months Forecast

Average 63.38 USD 8.43%

High 63.5 USD

Low 63 USD

Based on 5 Wall Street analysts offering 12 month price targets forCatalent Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

3

Hold

1

Sell

Based on 5 analysts giving stock ratings to Catalent Inc - Dist in the past 3 months.

Technical Score

By Trading Central

58.07 / N/ASupport & Resistance

Recent bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

123 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Catalent Inc

Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.

Other stocks from the sector

LLY

Eli Lilly and Co.

802.55

UNH

UnitedHealth Group Inc

569.62

NVO

Novo Nordisk A-S

126.83

JNJ

Johnson and Johnson

160.55

MRK

Merck & Co Inc.

125.13